The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The heme oxygenase/biliverdin reductase (HO/BVR) axis catalyzes the degradation of heme, but this system and its by-products, carbon monoxide (CO) and bilirubin, have also been shown to exert cytoprotective effects by activating pro-survival pathways and scavenging free radicals. Naturally occurring substances that upregulate the inducible isoform of HO (HO-1) have therefore been proposed as potential new drugs for the treatment of free radical-induced disease. A number of existing drugs have also been shown to regulate the HO/BVR system, and this capacity is considered an additional mechanism for their therapeutic activity. However, upregulation of the HO/BVR axis is not always beneficial for cells: the heme depletion and accumulation of CO and bilirubin it causes are potentially toxic. Therefore, new pharmacological modulators of HO/BVR activity must act in a dose-dependent manner. This would allow dose titration to achieve a desired pharmacologic effect without producing toxicity. Unfortunately, this goal is more complicated than it seems because toxicity has to be defined in terms of each of the main products of heme metabolism. Furthermore, sensitivity to the therapeutic/toxic effects of these products is likely to be tissue- or cell-type specific. The solution may lie in the use of novel drug-delivery systems that allow targeted delivery of low doses of the HO/BVR modulator to selected tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications
Maines, M. D. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.10.3290025 · Cited by 1,707 · cited 2×
“1), a lipophilic molecule with strong antioxidant activity [1,2,10].”
BackgroundNitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., & Giuffrida Stella, A. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2214 · Cited by 1,543 · cited 2×
“The result is an increase in the half-life of NO/sGC-derived cGMP, which enhances and prolongs smooth-muscle relaxation in the corpora cavernosa that allows penile erection [17].”
BackgroundSelf-citationHemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 gene
Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf516 · Cited by 637 · cited 3×
“However, in cultured human and rodent cells, HO-1 expression is repressed by hypoxia, cigarette smoke, or treatment with interferon- or desferrioxamine [31,36]; HO-1 repression occurs when the heterodimerization partners of MafK are the transcription factors Bach1 or Bach2 [33,35].”
BackgroundStewart, D., Killeen, E., Naquin, R., Alam, S., & Alam, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209195200 · Cited by 463 · cited 1×
“Both contain multiple stress-responsive elements (also known as antioxidantresponsive elements), which share a consensus sequence (GCnnnGTA) with the Maf recognition element (MARE) [34].”
BackgroundChen, C.-Y., Jang, J.-H., Li, M.-H., & Surh, Y.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.237 · Cited by 428 · cited 1×
“More recently, it has also been shown to increase HO-1 expression in PC12 cells (presumably by activating Nrf2) and in primary rodent neuron cultures [209,210].”
BackgroundSawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706241 · Cited by 391 · cited 1×
“The fact that CO exposure causes overproduction of mitochondrial ROS, induction of HO-1 protein expression [93], and acute reductions in the intracellular GSH content suggests that, although it is clearly capable of producing antioxidant effects, CO is first and foremost a pro-oxidant (Fig.”
BackgroundMitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.
Zhang, J., & Piantadosi, C. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115980 · Cited by 320 · cited 1×
“In rats exposed to exogenous CO, mitochondrial production of hydrogen peroxide increases in the forebrain, an effect that is probably caused by oxidative damage at the cytochrome oxidase level and reductions in the reduced/oxidized glutathione (GSH) ratio [89,90] (Fig.”
BackgroundCarbon monoxide, reactive oxygen signaling, and oxidative stress
Piantadosi, C. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.013 · Cited by 281 · cited 4×
“Carbon monoxide and bilirubin also help maintain the cell’s redox equilibrium by activating important pro-survival signalling pathways, such as those involving the proto-oncogene Akt or the mitogen-activated protein kinase family (MAPK), and by scavenging reactive oxygen and nitrogen species (ROS and RNS, respectively…”
BackgroundInfluentialBasuroy, S., Bhattacharya, S., Leffler, C. W., & Parfenova, H. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00381.2008 · Cited by 254
Taillé, C., El-Benna, J., Lanone, S., Boczkowski, J., & Motterlini, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503512200 · Cited by 246 · cited 2×
“human smooth muscle cells [91,92].”
BackgroundVolak, L. P., Ghirmai, S., Cashman, J. R., & Court, M. H. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020552 · Cited by 214
Cited by
Ferulic acid: Pharmacological and toxicological aspects
Mancuso, C., & Santangelo, R. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.024 · Cited by 572
Self-citationVerdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 495
Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Iavicoli, I., Di Paola, R., Koverech, A., Cuzzocrea, S., Rizzarelli, E., & Calabrese, E. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.002 · Cited by 420
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402
Self-citation
Metadata
- Authors
- Mancuso, C., & Barone, E.
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-07-01
- Volume
- 10
- Issue
- 6
- Pages
- 579-594
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2036431724
- Cited by
- 98
- References
- 11
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.